Skip to main content

Table 2 Number of evaluable cases and overall RT compliance

From: Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202

 

number

(%)

Total

283

 

   Data insufficient/partially evaluable

62

 

   Off-protocol

12

 

   Ineligible

5

 

Fully evaluable

204

(100)

   PPoverall

158

(77)

   DAoverall

29

(14)

   VUoverall

17

(8)

Compliance (PPoverall+DAoverall)

187

(92)

  1. Abbreviations: PP, per protocol; DA, deviation acceptable; VU, violation unacceptable